Handl Health and the Death of Cost Shifting (with Ahmed Marmoush, Co-founder and CEO of Handl Health)

Blake Madden
Blake Madden
September 1, 2026

Blake sits down with Ahmed Marmoush, CEO and co-founder of Handl Health, fresh off their Series A funding, and this one covers the full arc of where employer-sponsored insurance is heading.

Ahmed’s path is unlike any guest we’ve seen on Claims Denied: From a clinical pharmacist in New Zealand’s single-payer system, to a consultant alongside the country’s former Director General of Health, to an $800 bill for a routine physical in LA that turned into a company. (They offered him 50% off if he paid within a few days. He compared it to haggling in an Egyptian street market. He’s not wrong.)

They get into why cost shifting is dead, how variable copay plans really work, what’s inside Handl’s value index, and why Ahmed is betting on being the enablement layer between brokers and carriers instead of building yet another health plan.

If you touch benefits strategy, brokerage, or health plan ops, this one’s worth the commute.

Navvis partners with health systems and health plans to deliver real performance improvement across value-based care and fee-for-service models.

⁠⁠⁠https://navvishealthcare.com/vbc⁠⁠⁠

For expert analysis on healthcare M&A, strategy, finance, and markets, join 68K+ readers of Blake Madden’s Hospitalogy newsletter. Subscribe here: ⁠⁠⁠⁠⁠⁠https://hospitalogy.com/⁠⁠⁠⁠⁠⁠

Like our podcast? Check our previous episodes of Claims Denied here: ⁠⁠⁠⁠⁠⁠https://hospitalogy.com/podcast/⁠⁠⁠⁠⁠⁠

Be sure to leave us a review, and share our podcast with colleagues.

Follow Ahmed on LinkedIn: https://www.linkedin.com/in/ahmed-marmoush-25169961/

Follow Blake Madden on LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/blakecmadden/⁠⁠⁠⁠⁠⁠⁠⁠

Blake Madden
Blake Madden